Abstract
We undertook a randomized clinical trial comparing therapeutic efficacy of the 1-day doxycycline regimen with the 5-day josamycin regimen for Mediterranean spotted fever. All 59 patients recovered uneventfully, and results did not significantly differ between the two schedules. One-day doxycycline therapy is an effective, easy, and inexpensive treatment. Josamycin is a useful therapeutic alternative that may be particularly convenient for pregnant women and patients with a history of allergy to tetracyclines.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bella-Cueto F., Font-Creus B., Segura-Porta F., Espejo-Arenas E., López-Parés P., Muñoz-Espín T. Comparative, randomized trial of one-day doxycycline versus 10-day tetracycline therapy for Mediterranean spotted fever. J Infect Dis. 1987 May;155(5):1056–1058. doi: 10.1093/infdis/155.5.1056. [DOI] [PubMed] [Google Scholar]
- Font-Creus B., Bella-Cueto F., Espejo-Arenas E., Vidal-Sanahuja R., Muñoz-Espin T., Nolla-Salas M., Casagran-Borrell A., Mercade-Cuesta J., Segura-Porta F. Mediterranean spotted fever: a cooperative study of 227 cases. Rev Infect Dis. 1985 Sep-Oct;7(5):635–642. doi: 10.1093/clinids/7.5.635. [DOI] [PubMed] [Google Scholar]
- Grossman E. R., Walchek A., Freedman H. Tetracyclines and permanent teeth: the relation between dose and tooth color. Pediatrics. 1971 Mar;47(3):567–570. [PubMed] [Google Scholar]
- Gudiol F., Pallares R., Carratala J., Bolao F., Ariza J., Rufi G., Viladrich P. F. Randomized double-blind evaluation of ciprofloxacin and doxycycline for Mediterranean spotted fever. Antimicrob Agents Chemother. 1989 Jun;33(6):987–988. doi: 10.1128/aac.33.6.987. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Muñoz-Espin T., López-Parés P., Espejo-Arenas E., Font-Creus B., Martinez-Vila I., Travería-Casanova J., Segura-Porta F., Bella-Cueto F. Erythromycin versus tetracycline for treatment of Mediterranean spotted fever. Arch Dis Child. 1986 Oct;61(10):1027–1029. doi: 10.1136/adc.61.10.1027. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Raoult D., Roussellier P., Galicher V., Perez R., Tamalet J. In vitro susceptibility of Rickettsia conorii to ciprofloxacin as determined by suppressing lethality in chicken embryos and by plaque assay. Antimicrob Agents Chemother. 1986 Mar;29(3):424–425. doi: 10.1128/aac.29.3.424. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Raoult D., Roussellier P., Tamalet J. In vitro evaluation of josamycin, spiramycin, and erythromycin against Rickettsia rickettsii and R. conorii. Antimicrob Agents Chemother. 1988 Feb;32(2):255–256. doi: 10.1128/aac.32.2.255. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Raoult D., Roussellier P., Vestris G., Tamalet J. In vitro antibiotic susceptibility of Rickettsia rickettsii and Rickettsia conorii: plaque assay and microplaque colorimetric assay. J Infect Dis. 1987 May;155(5):1059–1062. doi: 10.1093/infdis/155.5.1059. [DOI] [PubMed] [Google Scholar]